Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.

Yu Chi Shen,Ravi Upadhyayula,Stephanie Cevallos,Ryan J. Messick,Tammy Hsia,Mathew P. Leese,Douglas M. Jewett,Daysha Ferrer-Torres,Therese M. Roth,Wolfgang Dohle,Barry V. L. Potter,Kate F. Barald

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.

2015

Yu Chi Shen
Ravi Upadhyayula
Stephanie Cevallos
Ryan J. Messick
Tammy Hsia
Mathew P. Leese
Douglas M. Jewett
Daysha Ferrer-Torres
Therese M. Roth
Wolfgang Dohle
Barry V. L. Potter
Kate F. Barald

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

Keywords:

Pathology
Immunology
Small molecule
Cancer cell
TOR Serine-Threonine Kinases
Cancer
Metabolite
Signal transduction
Small Molecule Libraries
Biology
Genetic enhancement

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations